Humana, Eli Lilly And A Major Mining Stock On CNBC's 'Final Trades'
Portfolio Pulse from Lisa Levin
On CNBC's 'Halftime Report Final Trades', Bryn Talkington of Requisite Capital Management recommended Freeport-McMoRan Inc. (FCX), which recently reported a 16.4% YoY revenue growth. Stephen Weiss of Short Hills Capital Partners mentioned Humana Inc. (HUM), which reported a higher than expected Q3 adjusted EPS. Joseph Terranova of Virtus Investment Partners named Eli Lilly and Company (LLY) as his final trade, which also reported better-than-expected Q3 results.
November 07, 2023 | 1:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Freeport-McMoRan reported a 16.4% YoY revenue growth, beating consensus estimates. The stock was recommended by Bryn Talkington of Requisite Capital Management.
The company's better-than-expected Q3 results and the recommendation by a reputable analyst are likely to have a positive impact on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Humana reported a higher than expected Q3 adjusted EPS. The stock was mentioned by Stephen Weiss of Short Hills Capital Partners.
The company's better-than-expected Q3 results and the mention by a reputable analyst are likely to have a positive impact on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Eli Lilly reported better-than-expected Q3 results. The stock was named as a final trade by Joseph Terranova of Virtus Investment Partners.
The company's better-than-expected Q3 results and the recommendation by a reputable analyst are likely to have a positive impact on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100